Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data
ConclusionsIn this study, the prevalence of Hr-TB among TB patients was higher than the prevalence of rifampicin resistance globally. Many patients with Hr-TB would be missed by current diagnostic algorithms driven by rifampicin testing, highlighting the need for new rapid molecular technologies to ensure access to appropriate treatment and care. The low prevalence of resistance to pyrazinamide and fluoroquinolones among patients with Hr-TB provides further justification for the recommended modified treatment regimen.
Source: PLoS Medicine - Category: Internal Medicine Authors: Anna S. Dean Source Type: research
More News: African Health | Antimicrobial Resistance | Azerbaijan Health | Bangladesh Health | Belarus Health | Epidemics | Epidemiology | Genetics | Internal Medicine | International Medicine & Public Health | Laboratory Medicine | Levaquin | Lice | Pakistan Health | Philippines Health | South Africa Health | Study | Tuberculosis | WHO